Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Fundamental Analysis

Europe - Euronext Dublin - DUB:UPR - IE00BJ5FQX74 - Common Stock

3.52 EUR
+0.02 (+0.57%)
Last: 12/18/2025, 7:00:00 PM
Fundamental Rating

5

Overall UPR gets a fundamental rating of 5 out of 10. We evaluated UPR against 31 industry peers in the Health Care Providers & Services industry. While UPR belongs to the best of the industry regarding profitability, there are concerns on its financial health. UPR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year UPR was profitable.
UPR had a positive operating cash flow in the past year.
UPR had positive earnings in each of the past 5 years.
UPR had a positive operating cash flow in each of the past 5 years.
UPR.I Yearly Net Income VS EBIT VS OCF VS FCFUPR.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

UPR has a Return On Assets of 4.25%. This is in the better half of the industry: UPR outperforms 77.42% of its industry peers.
With an excellent Return On Equity value of 17.78%, UPR belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
UPR has a Return On Invested Capital of 8.91%. This is amongst the best in the industry. UPR outperforms 87.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UPR is above the industry average of 6.10%.
Industry RankSector Rank
ROA 4.25%
ROE 17.78%
ROIC 8.91%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
UPR.I Yearly ROA, ROE, ROICUPR.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

UPR has a Profit Margin (2.30%) which is comparable to the rest of the industry.
UPR's Profit Margin has improved in the last couple of years.
The Operating Margin of UPR (3.01%) is worse than 61.29% of its industry peers.
In the last couple of years the Operating Margin of UPR has grown nicely.
UPR has a worse Gross Margin (15.25%) than 61.29% of its industry peers.
UPR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.01%
PM (TTM) 2.3%
GM 15.25%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
UPR.I Yearly Profit, Operating, Gross MarginsUPR.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UPR is creating some value.
Compared to 1 year ago, UPR has about the same amount of shares outstanding.
Compared to 5 years ago, UPR has about the same amount of shares outstanding.
The debt/assets ratio for UPR has been reduced compared to a year ago.
UPR.I Yearly Shares OutstandingUPR.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
UPR.I Yearly Total Debt VS Total AssetsUPR.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

UPR has an Altman-Z score of 2.63. This is not the best score and indicates that UPR is in the grey zone with still only limited risk for bankruptcy at the moment.
UPR has a Altman-Z score of 2.63. This is in the better half of the industry: UPR outperforms 64.52% of its industry peers.
A Debt/Equity ratio of 1.21 is on the high side and indicates that UPR has dependencies on debt financing.
UPR has a Debt to Equity ratio (1.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 2.63
ROIC/WACC1.24
WACC7.16%
UPR.I Yearly LT Debt VS Equity VS FCFUPR.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

UPR has a Current Ratio of 0.95. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
UPR's Current ratio of 0.95 is in line compared to the rest of the industry. UPR outperforms 51.61% of its industry peers.
UPR has a Quick Ratio of 0.95. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
UPR's Quick ratio of 0.65 is on the low side compared to the rest of the industry. UPR is outperformed by 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.65
UPR.I Yearly Current Assets VS Current LiabilitesUPR.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

UPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.84%, which is quite good.
Measured over the past years, UPR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.47% on average per year.
Looking at the last year, UPR shows a small growth in Revenue. The Revenue has grown by 7.73% in the last year.
The Revenue has been growing by 10.72% on average over the past years. This is quite good.
EPS 1Y (TTM)16.84%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%20.99%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%8.62%

3.2 Future

UPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.49% yearly.
Based on estimates for the next years, UPR will show a small growth in Revenue. The Revenue will grow by 1.90% on average per year.
EPS Next Y13.92%
EPS Next 2Y11.24%
EPS Next 3Y10.93%
EPS Next 5Y19.49%
Revenue Next Year8.39%
Revenue Next 2Y6.99%
Revenue Next 3Y6.46%
Revenue Next 5Y1.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UPR.I Yearly Revenue VS EstimatesUPR.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
UPR.I Yearly EPS VS EstimatesUPR.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

UPR is valuated correctly with a Price/Earnings ratio of 16.00.
Compared to the rest of the industry, the Price/Earnings ratio of UPR is on the same level as its industry peers.
When comparing the Price/Earnings ratio of UPR to the average of the S&P500 Index (26.38), we can say UPR is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.85 indicates a correct valuation of UPR.
UPR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UPR is cheaper than 61.29% of the companies in the same industry.
UPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16
Fwd PE 13.85
UPR.I Price Earnings VS Forward Price EarningsUPR.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

UPR's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.45
UPR.I Per share dataUPR.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

UPR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
UPR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.15
PEG (5Y)1.03
EPS Next 2Y11.24%
EPS Next 3Y10.93%

3

5. Dividend

5.1 Amount

UPR has a yearly dividend return of 0.87%, which is pretty low.
UPR's Dividend Yield is comparable with the industry average which is at 1.72.
Compared to an average S&P500 Dividend Yield of 1.87, UPR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

The dividend of UPR is nicely growing with an annual growth rate of 33.58%!
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
UPR.I Yearly Dividends per shareUPR.I Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

7.65% of the earnings are spent on dividend by UPR. This is a low number and sustainable payout ratio.
UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.65%
EPS Next 2Y11.24%
EPS Next 3Y10.93%
UPR.I Yearly Income VS Free CF VS DividendUPR.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
UPR.I Dividend Payout.UPR.I Dividend Payout, showing the Payout Ratio.UPR.I Dividend Payout.PayoutRetained Earnings

UNIPHAR PLC

DUB:UPR (12/18/2025, 7:00:00 PM)

3.52

+0.02 (+0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-02 2025-09-02/bmo
Earnings (Next)02-23 2026-02-23
Inst Owners50.68%
Inst Owner ChangeN/A
Ins Owners5.1%
Ins Owner ChangeN/A
Market Cap913.69M
Revenue(TTM)2.89B
Net Income(TTM)66.31M
Analysts81.67
Price Target4.93 (40.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP7.65%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.49%
EPS NY rev (3m)0.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 16
Fwd PE 13.85
P/S 0.32
P/FCF N/A
P/OCF 11.86
P/B 2.45
P/tB N/A
EV/EBITDA 10.45
EPS(TTM)0.22
EY6.25%
EPS(NY)0.25
Fwd EY7.22%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.3
OCFY8.43%
SpS11.13
BVpS1.44
TBVpS-0.75
PEG (NY)1.15
PEG (5Y)1.03
Graham Number2.67
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 17.78%
ROCE 10.46%
ROIC 8.91%
ROICexc 10.42%
ROICexgc 52%
OM 3.01%
PM (TTM) 2.3%
GM 15.25%
FCFM N/A
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
ROICexc(3y)10.45%
ROICexc(5y)10.56%
ROICexgc(3y)82.98%
ROICexgc(5y)N/A
ROCE(3y)10.62%
ROCE(5y)10.36%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.71%
ROICexc growth 5Y-1.65%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
F-Score6
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA 3.71
Cap/Depr 256.32%
Cap/Sales 3.06%
Interest Coverage 2.99
Cash Conversion 63.41%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.65
Altman-Z 2.63
F-Score6
WACC7.16%
ROIC/WACC1.24
Cap/Depr(3y)149.63%
Cap/Depr(5y)116.24%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.5%
Profit Quality(3y)72.81%
Profit Quality(5y)95.5%
High Growth Momentum
Growth
EPS 1Y (TTM)16.84%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%20.99%
EPS Next Y13.92%
EPS Next 2Y11.24%
EPS Next 3Y10.93%
EPS Next 5Y19.49%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%8.62%
Revenue Next Year8.39%
Revenue Next 2Y6.99%
Revenue Next 3Y6.46%
Revenue Next 5Y1.9%
EBIT growth 1Y9.19%
EBIT growth 3Y12.44%
EBIT growth 5Y16.03%
EBIT Next Year50.28%
EBIT Next 3Y21.11%
EBIT Next 5Y14.6%
FCF growth 1Y-131.28%
FCF growth 3Y-16.24%
FCF growth 5Y-26.09%
OCF growth 1Y30.27%
OCF growth 3Y33.54%
OCF growth 5Y3.04%

UNIPHAR PLC / UPR.I FAQ

Can you provide the ChartMill fundamental rating for UNIPHAR PLC?

ChartMill assigns a fundamental rating of 5 / 10 to UPR.I.


Can you provide the valuation status for UNIPHAR PLC?

ChartMill assigns a valuation rating of 4 / 10 to UNIPHAR PLC (UPR.I). This can be considered as Fairly Valued.


What is the profitability of UPR stock?

UNIPHAR PLC (UPR.I) has a profitability rating of 7 / 10.


What is the earnings growth outlook for UNIPHAR PLC?

The Earnings per Share (EPS) of UNIPHAR PLC (UPR.I) is expected to grow by 13.92% in the next year.


Can you provide the dividend sustainability for UPR stock?

The dividend rating of UNIPHAR PLC (UPR.I) is 3 / 10 and the dividend payout ratio is 7.65%.